Exelixis director plans $374K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mary Beckerle, a director of Exelixis, Inc. (EXEL), listed 7,712 common shares for sale, with an aggregate market value of $373,646.40. The notice gives an approximate sale date of May 7, 2026, and names Morgan Stanley Smith Barney LLC as the broker. The listed shares include 3,856 shares from restricted stock vesting on January 5, 2026, and 3,856 shares from an option exercise on May 7, 2026; both acquisitions were under registered plans.
Key Figures
Key Terms
Restricted stock vesting under a registered plan technical
Exercise of options under a registered plan technical
Aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.